Is Pain Intensity Reduced by the Application of Kinesio Tape in Postmenopausal Women with Mild to Moderate Venous Insufficiency? by Ortiz Chavez, Yeimi
Philadelphia College of Osteopathic Medicine 
DigitalCommons@PCOM 
PCOM Physician Assistant Studies Student 
Scholarship Student Dissertations, Theses and Papers 
2020 
Is Pain Intensity Reduced by the Application of Kinesio Tape in 
Postmenopausal Women with Mild to Moderate Venous 
Insufficiency? 
Yeimi Ortiz Chavez 
Philadelphia College of Osteopathic Medicine 
Follow this and additional works at: https://digitalcommons.pcom.edu/pa_systematic_reviews 
 Part of the Medicine and Health Sciences Commons 
Recommended Citation 
Ortiz Chavez, Yeimi, "Is Pain Intensity Reduced by the Application of Kinesio Tape in Postmenopausal 
Women with Mild to Moderate Venous Insufficiency?" (2020). PCOM Physician Assistant Studies Student 
Scholarship. 562. 
https://digitalcommons.pcom.edu/pa_systematic_reviews/562 
This Selective Evidence-Based Medicine Review is brought to you for free and open access by the Student 
Dissertations, Theses and Papers at DigitalCommons@PCOM. It has been accepted for inclusion in PCOM 
Physician Assistant Studies Student Scholarship by an authorized administrator of DigitalCommons@PCOM. For 












Is Pain Intensity Reduced by the Application of Kinesio Tape in Postmenopausal Women 







Yeimi Ortiz Chavez , PA-S 
 
A SELECTIVE BASED MEDICINE REVIEW  
 




Health Science- Physician Assistant  
 
 
Department of Physician Assistant Studies 
Philadelphia College of Osteopathic Medicine  






















OBJECTIVE: The objective of this selective evidence based medicine (EBM) review is to 
determine whether or not “Is pain intensity reduced by the application of kinesio tape in 
postmenopausal women with mild to moderate venous insufficiency?” 
 
STUDY DESIGN: A systemic review compiling data from three randomized controlled trials 
between 2013 and 2014, all in the English language.  
 
DATA SOURCES: Three pertinent studies evaluating the reduction of pain intensity in 
postmenopausal women with mild to moderate chronic venous insufficiency were included in 
this review. Sources were selected using PubMed and Cochrane Library. 
 
OUTCOME(S) MEASURED: Patient perception of pain using a Visual Analog Scale (VAS) of 
0-10.  
 
RESULTS: Within group comparisons demonstrated a statistically significant difference in pain 
amongst the group receiving kinesio tape intervention. Aguilar-Ferrandiz et al. 2014a found the 
increase in VAS score was 3.12 (2.61, 3.63) for the experimental group and 0.37 (0.16, 0.59) for 
the control group with a 95% CI, p=0.016 (Clin Rehabil. 2014a; 28(1):69-81. doi: 
10.1177/0269215512469120). A Cohen’s d score of 1.73 for the experimental and 0.17 for the 
control group, indicates a greater reduction in pain intensity in the experimental group (Aguilar-
Ferrandiz ME, Castro-Sanchez AM, Mataran-Penarrocha GA, et al. Clin Rehabil. 2014a; 
28(1):69-81.doi: 10.1177/0269215512469120). The Aguilar-Ferrandiz et al. 2013 study reported 
an increase in VAS of 2.10 (1.90-2.50) in the experimental group and 0.32 (0.07 -0.57) in the 
control group with a 95% CI, p=0.003 (Arch Phys Med Rehabil. 2013; 94(12):2315-2328. 
doi:10.1016/j.apmr.2013.05.016). In Aguilar Ferrandiz 2014b the increase in VAS score of the 
experimental group was 2.79 (2.16, 3.41) with a 95% CI, p=0.001 (Arch Phys Med Rehabil. 
2014b; 95(7):1229-1239. doi:10.1016/j.apmr.2014.03.024). The increase in VAS score for the 
control group was 0.25 (0.02, 0.48) with a CI 95%, p=0.036 (Aguilar-Ferrándiz ME, Moreno-
Lorenzo C, Matarán-Peñarrocha GA, et al. Arch Phys Med Rehabil.2014b; 95(7):1229-1239. doi: 
10.1016/j.apmr.2014.03.024). Cohen’s d score for the experimental group was 1.470 and the 
control was 0.115, indicating that there was a significant difference with treatment over time in 
the experimental group, but little change for the control group (Aguilar-Ferrándiz ME, Moreno-
Lorenzo C, Matarán-Peñarrocha GA, et al. Arch Phys Med Rehabil. 2014b; 95(7):1229-1239. 
doi: 10.1016/j.apmr.2014.03.024). 
 
CONCLUSIONS: The evidence presented in this review demonstrates that kinesio tape (KT) is 
an effective treatment option to reduce pain intensity in postmenopausal women with mild to 
moderate chronic venous insufficiency, however the impact of visual colors and proprioceptive 
cutaneous afferents from the KT may have a  placebo effect.  
 
KEYWORDS: Kinesio, tape, randomized control trial, postmenopausal  
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INTRODUCTION 
Chronic venous insufficiency (CVI) is a condition that worsens with age. It is 
characterized by venous hypertension in the lower extremities and venous reflux, which occurs 
when the valves in the veins do not function properly, leading to reversal of blood flow through 
the valves.1 The increase in pressure from the incompetent valves and resulting thrombosis 
destroy the valves.1 Deep and superficial veins become distended from excess volume, further 
distorting venous vessel walls, leading to further venous dilation and valve incompetence.1 As a 
result of this inflammation, increased expression of proteinases by the vessel cells breaks down 
the extracellular matrix and leads to further abnormal vascular permeability and edema.2 Regular 
contractions of the gastrocnemius muscle contribute to venous return, therefore lack of exercise 
can lead to CVI.3-5 CVI presentation can include pain, leg heaviness, muscle cramps, itching, 
dilated veins, edema, lipodermatosclerosis, brown skin hyperpigmentation or ulceration of the 
lower limbs.3-5 
CVI affects greater than 30 million adults in the U.S., with 17% prevalence in men and 
40% in women.2 The incidence of CVI is highest in western countries and is expected to rise as 
the population ages and obesity becomes more common. As Americans live longer, the number 
of patients with CVI will increase.2 In 2006 there were six million outpatient visits for CVI in the 
U.S. and this number is projected to grow.6 CVI consumes 2% of the healthcare budget, with the 
direct medical cost of CVI in the U.S. estimated to be three billion dollars annually.2 
Postmenopausal women have a high predisposition to CVI because of a combination of various 
risk factors, including age, gender, family history of venous disease, sedentary life style, obesity, 
lower extremity trauma, prolonged standing, and multiple pregnancies.3   
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The severity of venous disease can be classified using the C0-C6 CEAP scoring system 
which is made up of four clinical components: (C) clinical signs, (E) etiology, (A) anatomy and 
(P) pathophysiology.6 The classification system includes C0 (no visible or palpable signs of 
venous disease), C1 (telangiectasia or reticular veins), C2 (varicose veins, diameter >3mm), C3 
(edema without skin changes), C4 (skin changes ascribed to venous disease- pigmentation, 
venous eczema, lipodermatosclerosis), C5 (healed venous ulcer) or  C6 (active venous ulcer).4,6 
For the purpose of this review mild to moderate CVI was classified as C1-C3.  
Current noninvasive methods for the treatment of CVI are leg elevation, exercise, and 
compression therapy (compression stockings 20-30 mmhg), which reduce vein caliber and 
improve venous hemodynamics by increasing venous return, improving lymphatic flow and 
cutaneous microcirculation.2 Additionally, it is recommended that individuals implement a 
healthy lifestyle and decrease their BMI, if necessary, to maintain an ideal body weight. Invasive 
management includes vein ablation methods involving surgical excision, sclerotherapy, or 
thermal ablation.2 Venous stenting and reconstruction are procedures offered for treatment based 
upon extreme severity and poor prior response to medical therapy.2 Not everyone is a candidate 
for an invasive procedure or surgery, and there is risk for infection. While leg elevation, exercise, 
and compression stockings may be the primary management for CVI, or an adjunct to medical 
therapy, there are often poor compliance rates of up to 33% especially in the presence of pain, 
exudates, skin irritation, aesthetic reasons, discomfort, and difficulty putting on the stockings.5 
Kinesio tape (KT) is a bandaging technique used to increase lymphatic and vascular flow, and 
decrease pain. 3,5 The thin composure and elasticity of the KT produces less mechanical restraint 
and allows for greater mobility as compared with conventional bandages, thus, KT may be used 
as an alternative method for maximal treatment adherence and reduction of pain intensity in CVI.  
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OBJECTIVE 
The objective of this selective evidence based medicine (EBM) review is to determine 
whether or not “Is pain intensity reduced by the application of kinesio tape in postmenopausal 
women with mild to moderate venous insufficiency?” 
METHODS 
 
The EBM review evaluates three double-blinded randomized controlled trials. The 
population of interest included postmenopausal women 50-75 years of age with mild to moderate 
CVI. The demographics of the included studies are listed in Table 1. KT application was used as 
an intervention in all three studies, with the control group, or placebo group, using a sham KT 
protocol. The outcomes measured in all three studies included pain intensity at baseline and after 
four weeks of treatment.  
A detailed literature search using Pubmed and Cochrane Library was performed. The 
initial search terms “kinesio tape” , “chronic venous insufficiency” , “randomized control trial” 
and “postmenopausal” were used  with appropriate search limits of a publish date after 2009 to 
identify relevant clinical studies of KT in CVI. The articles were selected based on patient 
oriented outcomes (POEMS) and relevance to the clinical question.  The articles were written in 
English and published in peer reviewed journals. The inclusion criteria when searching for 
articles included full-text, randomized control trial, published within the last 10 years, and 
postmenopausal women. Exclusion criteria included articles published before 2009, studies about 
animals and non-post-menopausal women. The statistics reported included p values, Cohen d 
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venous thrombotic 
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to KT  technique: thrombosis, 
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allergy to KT tape and 
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OUTCOMES MEASURED  
 
All three studies measured pain intensity using a 10-cm visual analog scale (VAS) 
ranging from 0 (no pain) to 10 (unbearable pain) as self-reported by the patient. Pain intensity 
was measured at baseline and three times a week during a four week period for all three patient 
oriented studies.  
RESULTS 
 
All three studies conducted were double-blinded randomized controlled trials, performed  
in Spain as outpatient interventions.3-5 In each study a vascular therapist collected patient data on 
age, body mass index, etiology, time since CVI onset, disability, predisposing factors, and 
pretreatment disease status. 3-5 The therapist classified patients as CEAP score C1-C3, based on 
criteria by the American Venous Forum committee.3-5 In order to make the classification, the 
patients were examined in sitting and standing positions and peripheral pulse was felt by 
palpation.3-5 Demographics and inclusion and exclusion criteria of participants are included in 
Table 1. Treatment allocation for each study was concealed and computer software was used to 
allocate each participant with a randomization code.3-5 All treatments were performed by a KT 
instructor with clinical experience who was blinded to outcome measure and baseline 
examination. The taping procedure used in the experimental and control groups was similar in all 
three studies. The experimental group received taping with three strips each of 5 cm x 5 m 
Kinesio Tex Gold following Kase guidelines.3-5 Two strips arranged in a Y shape were applied to 
the medial gastrocnemius and the lateral gastrocnemius muscle to enhance gastrocnemius muscle 
activation.3-5 For application, participants were in a prone position with tape tension ranging 
from 15% to 50% from the tape origin to insertion site. 3-5 Next, an I-stripe was placed in the 
supine position at maximum dorsiflexion and applied with 50% tension. 3-5 An additional two 
pieces of tape were placed with 50% tension at the malleolar level to exert peripheral venous 
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compression.3-5 The placebo group received an identical number of strips of sham tape, except 
application was without tension and Kinesio taping guidelines were not followed. Despite 
differences tape application was similar in appearance. Compliance in all three studies was based 
on patient treatment intervention being performed three times a week during the four week 
period. In each of the three studies assessed in this EBM review, data was presented as 
continuous and could not be converted into dichotomous form within the studies.     
In Aguilar Ferrandiz 2014a et al., 130 women were screened and 120 met the selection 
criteria and were randomized into an experimental group which received KT application (n=60), 
or to a placebo-control group which received a sham protocol (n=60). In the experimental and 
control group, ten and six participants respectively did not receive the allocated intervention.3 
The study followed the intention-to-treat analysis and subjects were analyzed as randomized and 
no comment was made regarding worse case analysis of lost subjects.  
 Researchers used a mean change from baseline, four weeks post treatment and a 95% CI 
for within and between-group change scores for pain in both experimental and control groups 
based on VAS.3 There was a significantly lower score in the experimental group compared to the 
control group for VAS (F = 23.94; p = 0.001) scores.3 Table 2 shows that while both the 
experimental and control groups started with relatively equal baseline VAS scores, (experimental 
5.63, control 5.28), four weeks post treatment the experimental group reported VAS scores of 
2.51± 1.54  (95%CI) while the control group reported VAS scores of 4.91±1.99 (95%CI).3 
Higher scores represent higher levels of pain. Within group, the experimental group showed a 
Cohen d of 1.73, which is a large change over time, while the control group showed a Cohen d of 
0.17, which is a very small change.3 The improvement in pain scores (Table 2) between before 
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and after treatment was significantly greater in the experimental group (VAS 3.12) than in the 
control group (VAS 0.37).3 
























5.28±2.36 4.91±1.99 0.17 0.37(0.16,0.59)   
 
The Aguilar-Ferrandiz et al. 2013 study was a double-blind, randomized controlled trial 
with concealed allocation. In this study, 160 women were screened and 123 met study selection 
criteria based on demographics shown in Table 1. The 123 participants were randomly assigned 
to an experimental group which received KT application (n= 62) or a placebo-control group 
which received a sham KT application (n= 61).4 Nine participants were lost to follow-up, six 
were from the experimental group and three from the control group.4 Lost subjects were still 
included in the intention to treat analysis and no comment was made within the study regarding 
worse case analysis of lost subjects. Table 3 shows baseline VAS scores of experimental, 5.7 and 
control 5.6. Four weeks post treatment the experimental group reported VAS scores of 3.6 (95% 
CI), while the control group reported VAS scores of 5.3 (95%CI).4 Within the experimental 
group, this represents a change of 2.10, with a 95% CI, which is consistent with a clinically 
worthwhile effect of 2.0.4 Therefore, there is a significant decrease in pain in the experimental 
group, but not in the control group (within group change over four weeks 0.32).4 Even so, the 
improvement in the experimental group is relatively low (at 2.0), given the VAS range of 0-10.4 
Table 3 shows the between group score change four weeks post treatment is -1.74 (95% CI -2.3-
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1.15) which is a significant difference in VAS scores between the experimental and control 
groups (p=0.003).4 
Table 3: Kinesio Tape vs control: Change in pain intensity in Aguilar-Ferrandiz et al. 20134 






















The Aguilar-Ferrandiz et al. 2014b was double-blind, randomized controlled trial. In this 
study, 170 women were screened and 130 met study selection criteria based on demographics 
shown in Tale 1. The 130 participants were randomly assigned to an experimental group, which 
received KT application (n= 65) or a placebo-control group, which received a sham-KT 
treatment (n= 65).5 Twelve participants were lost to follow-up, five were from the experimental 
group and seven participants from the control group. Lost participants were included in the 
intention to treat analysis and no comment was made within the study regarding worse case 
analysis of lost subjects. The study effect size was calculated  according to Cohen’s d statistic, 
for the experimental and control group, respectively, 1.470 and 0.115, as indicated in Table 4.5 A 
Cohen d score ≥0.80 is considered a large difference and a score <0.20 is a negligible difference, 
thus pain was reduced with greater intensity in the experimental group when compared to the 
control.5 Table 4 shows that the results of the Aguilar-Ferrandiz et al. 2014b also showed a 
between groups significant difference four weeks post treatment (F=62.31, p=0.001).  Within 
group comparisons demonstrated significant differences between baseline (5.58) and four weeks 
post treatment (2.79, 95% CI) for VAS (p=0.001) in the experimental group, and for the control 
group (baseline 5.29, four weeks post treatment 5.03, 95% CI) (p=0.036).5 Even though both 
groups showed a reduction in pain, the improvement in pain was significantly greater in the 
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experimental group, as shown by the between group change over four weeks of 2.25 (1.49-3.01, 
95% CI) and p=0.001.5 



















5.58±2.09 2.79±1.67 1.470 2.79±(2.16,3.41) 2.25(1.49,3.01) 0.001 
Control 
group 
5.29±2.33 5.03±2.17 0.115 0.25±(0.02,0.48)  0.036 
 
No adverse events occurred as a result of KT or sham tape application in any of the three 
studies. Intervention assigned to each group within the studies was well tolerated by participants.  
DISSCUSSION  
 
The number of patients diagnosed with CVI is increasing and although non-invasive 
treatments, such as leg elevation, compression stockings and exercise, are commonly 
implemented, a more adherent option is desired. KT can be rapidly applied, is air permeable and 
water resistant, and can be worn during exercise, characteristics that can help increase 
compliance with therapy in comparison to other compression systems.3 The three studies showed 
a more statistically significant decrease in pain intensity in postmenopausal women with CVI 
after four weeks of standardized KT treatment in comparison to the placebo groups.3-5 No 
outliers were addressed in any of the three studies.  
Pain levels were also positively affected in the placebo group, suggesting there may be a 
placebo effect on pain. The placebo groups in all three studies experienced post treatment 
improvement in pain intensity, although the reduction in pain intensity was smaller than in the 
experimental groups.3-5 The input of visual KT colors and proprioceptive cutaneous afferents 
may produce a belief  that the tape provides a positive therapeutic effect on CVI, improving 
perception of stability, confidence, and reassurance.3-5 
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This review studied the effects of KT on pain intensity in CVI, but KT and pain reduction 
has been studied in numerous different clinical scenarios. Abolhasani et al. 2019 showed KT as 
having a positive effect for reducing pain in patients with osteoarthritis of the knee.7 Shakeri et 
al. 2018 reported a significant decrease in pain intensity by application of KT in patients with  
lateral epicondylitis and myofascial trigger point in forearm muscles.8 Aghapour et al. 2017 
showed statistically significant reduction in pain and improved functional performance of the 
vastus medialis oblique and quadriceps muscle in athletes with patellofemoral pain syndrome.9 
These are a few notable studies that have reported positive effects from KT in reduction of pain 
intensity in other areas of the body.  
There is currently no research of long term effects of KT on skin, thus it could potentially 
be a limitation in clinical application.3 KT is relatively inexpensive, although multiple 
applications over a longer period can become costly. One roll of KT tape costs between $12-$17, 
multipack of up to 6 count cost $65. KT application is currently not covered by insurance and 
has not been proposed as a stand-alone intervention for CVI.  
The participants in all three studies analyzed here were 50-75 year old postmenopausal 
women, therefore results cannot be generalized to premenopausal women or men. Studies that 
include both genders would be beneficial because although there is a higher incidence of CVI in 
older women as compared to men, CVI is known to occur at earlier ages and in both genders. A 
four week treatment period could be considered another limitation. These issues can be 
overcome in future studies by application of KT over a longer time period and studying a more 
generalized population. Another confounding factor could be an individual’s perception of pain, 
which can be subjective and involves physical and psychological factors. All studies used a VAS 
scale, which depends on patient honesty of pain intensity felt. Some individuals are more tolerant 
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of pain than others. Further studies with a more in depth patient history and a standardized scale 
for pain can ensure more reliable results.  
CONCLUSION 
Based on the three randomized control trials, there is satisfactory data to conclude that 
pain intensity is reduced by the application of KT in postmenopausal women with mild to 
moderate CVI.3-5 Future studies are warranted to compare the shape, direction and tensile force 
of KT over muscle to determine optimal  KT application techniques for pain reduction. 
The effectiveness of KT as adjunctive therapy with physiotherapy treatments should also 
be considered.3-5 A consistent inclusion and exclusion criteria was included among all three 
studies, however future studies may benefit from a more standardized history and physical 
analysis of the patient. Family history of varicose veins and blood clots, previous leg injuries, 
and environmental and behavioral factors, such as prolonged standing or sitting posture at work, 
can be taken into consideration when determining a sample group. Finally, although all 
participants in the experimental groups showed a significant reduction of pain in all studies, all 
control groups also showed decreased pain, although not as significant a decrease. This indicates 
there is most likely a placebo effect from any kind of taping or treatment used in the controls and 
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